Mortality reductions due to mammography screening: Contemporary population-based data

PLoS ONE

Volumn 12, Issue 12, 2017, Pages

  Hanley, James A ^a   Hannigan, Ailish ^b   O’Brien, Katie M ^c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF LIMERICK   (Ireland)

^c NATIONAL CANCER REGISTRY IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; IRELAND; MAMMOGRAPHY; MORTALITY RATE; STEADY STATE; BREAST TUMOR; DIAGNOSTIC IMAGING; INCIDENCE; MIDDLE AGED; MORTALITY; REGISTER; UTILIZATION;

BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; IRELAND; MAMMOGRAPHY; MIDDLE AGED; REGISTRIES;

EID: 85038940278     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0188947     Document Type: Article

References (22)

1. Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen M-B et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005; 330:220–4. http://dx.doi.org/10.1136/bmj.38313.639236.82 PMID: 15649904
2. Njor SH, Schwartz W, Blichert-Toft M, Lynge E. Decline in breast cancer mortality: How much is attributable to screening? J Med Screen 2015; 22(1):20–27. https://doi.org/10.1177/0969141314563632PMID: 25492943
3. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011; 343:d4411. https://doi.org/10.1136/bmj.d4411 PMID: 21798968
4. Kalager M, Zelen M, Langmark F, Adami HO. (2010). Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med, 363(13), 1203–1210. https://doi.org/10.1056/NEJMoa1000727PMID: 20860502
5. Chu KC, Miller BA, Feuer EJ, Hankey BF. (1994). A method for partitioning cancer mortality trends by factors associated with diagnosis: An application to female breast cancer. J Clin Epidemiol, 47(12), 1451–1461. PMID: 7730854
6. Njor S, Nystrom L, Moss S, Paci E, Broeders M, Segnan N et al. Breast cancer mortality in mammo-graphic screening in Europe: a review of incidence-based mortality studies. J Med Screen 2012; 19 (Suppl 1): 33–41. https://doi.org/10.1258/jms.2012.012080 PMID: 22972809
7. Kalager M, Loberg M, Bretthauer M, Adami H-O. Comparative analysis of breast cancer mortality following mammography screening in Denmark and Norway. Ann Oncol 2014; 25(6): 1137–1143. https://doi.org/10.1093/annonc/mdu122 PMID: 24669012
8. Weedon-Fekjær H, Romundstad PR, Vatten LJ. Modern mammography screening and breast cancer mortality: population study. BMJ 2014; 348:g3701 https://doi.org/10.1136/bmj.g3701 PMID: 24951459
9. Miettinen OS. Mammographic screening: no reliable supporting evidence? Lancet 2002; 359:404–406. https://doi.org/10.1016/S0140-6736(02)07592-X PMID: 11844515
10. Hanley J. Analysis of mortality data from cancer screening studies: Looking in the right window. Epidemiology 2005; 16: 786. https://doi.org/10.1097/01.ede.0000181313.61948.76 PMID: 16222169
11. Liu Z, Hanley JA, Strumpf EC. Projecting the yearly mortality reductions due to a cancer screening program. J Med Screen 2013; 20:156–164. https://doi.org/10.1177/0969141313504088 PMID: 24045921
12. Törnberg S, Codd M, Rodrigues V, Segnan N, Ponti A. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European cen-tres. J Med Screen 2005; 12(1):43–9. https://doi.org/10.1258/0969141053279077 PMID: 15814019
13. BreastCheck annual reports. www.breastcheck.ie/content/annual_reports
14. European Commission. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th edn. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, eds. Luxembourg: Office for Official Publications of the European Communities, 2006. http://www.euref.org/ european-Guidelines
15. National Screening Service. Guidelines for quality assurance in mammography screening. 4th edn. Dublin: National Screening Service, 2015. http://www.breastcheck.ie/sites/default/files/bcheck/documents/guidelines_for_quality_assurance_in_mammography_screening.pdf
16. O’Brien K, Comber H, Sharp L. Completeness of case ascertainment at the Irish National Cancer Registry. Ir J Med Sci 2014; 183:219–24. https://doi.org/10.1007/s11845-013-0993-z PMID: 23955644
17. Kelly A, Teljeur C. A new national deprivation index for health and health services research: Short report. Small Area Health Research Unit (SAHRU), Department of Public Health and Primary Care. Dublin: Trinity College, 2004. SAHRU National Deprivation Index [Online]. Available from: http://www.thehealthwell.info/node/464302
18. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume II: The design and analysis of cohort studies. IARC Scientific Publications No. 82. International Agency for Research on Cancer, Lyon 1987. Equation 3.17, page 109.
19. Joinpoint. available from https://surveillance.cancer.gov/joinpoint/
20. Clayton D, Hills M. Statistical Models in Epidemiology. ISBN 0-19-852221-5, Oxford University Press, New York. 1993.
21. Commission of the European Communities. Proposal for a council recommendation on cancer screening. 2003/0093 (CNS). Brussels, 5 May, 2003. http://ec.europa.eu/health/ph_determinants/genetics/documents/com_2003_0230_en.pdf
22. Thompson SG, Ashton HA, Gao L, Buxton MJ, Scott RA on behalf of the Multicentre Aneurysm Screening Study (MASS) Group. Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg 2012; 99: 1649–1656. https://doi.org/10.1002/bjs.8897 PMID: 23034729